Psychiatry and Neurology, Neurology · Farmington Hills, MI
NPI
1962472241
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
28595 Orchard Lake Rd, Suite 200
Farmington Hills, MI, 48334
Phone (248) 553-0010
Groups this clinician bills Medicare through
Medicare paid, 2024
$515K
74,144 services
Medicare patients, 2024
570
Average age 72
Drug cost, 2024
$3.9M
4,907 prescriptions
Company payments, 2025
$473K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aaron L Ellenbogen was code J0585 (injection, onabotulinumtoxina, 1 unit), 51,090 times for 77 patients. In total Aaron L Ellenbogen billed 74,144 services in 43 codes, and Medicare paid $515K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-02-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 51,090 | 77 | $4.83 | $247K |
| J0586 Injection, abobotulinumtoxina, 5 units | Office | 9,640 | 18 | $6.77 | $65K |
| 99214 Office E&M - Established | Office | 428 | 269 | $86.91 | $37K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 276 | 173 | $12.56 | $3,468 |
| 95874 Musculoskeletal | Office | 243 | 82 | $54.56 | $13K |
| 64616 Musculoskeletal | Office | 191 | 59 | $160.94 | $31K |
| 64612 Musculoskeletal | Office | 96 | 32 | $125.40 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 80 | 63 | $61.49 | $4,919 |
| 99204 Office E&M - New | Office | 65 | 65 | $114.55 | $7,446 |
| 99222 Hospital E&M - Initial | Facility | 54 | 54 | $98.10 | $5,297 |
| 99215 Office E&M - Established | Office | 38 | 32 | $132.85 | $5,048 |
| 64615 Musculoskeletal | Office | 37 | 11 | $125.27 | $4,635 |
| 99213 Office E&M - Established | Office | 27 | 26 | $48.60 | $1,312 |
| 64644 Musculoskeletal | Office | 27 | 11 | $138.49 | $3,739 |
By year: 2022 $603K for 76,863 services; 2023 $572K for 77,689 services; 2024 $515K for 74,144 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aaron L Ellenbogen prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,032 prescriptions and refills. In total Aaron L Ellenbogen wrote 4,907 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,032 | 2,417 | 341 | $59K |
| Clonazepam Generic | 195 | 354 | 44 | $1,948 |
| Amantadine Amantadine Hcl | 156 | 297 | 45 | $9,622 |
| Rytary Carbidopa/Levodopa | 152 | 292 | 36 | $241K |
| Gabapentin Generic | 139 | 303 | 51 | $3,467 |
| Donepezil Hcl Generic | 129 | 318 | 45 | $1,992 |
| Memantine Hcl Generic | 125 | 243 | 29 | $3,753 |
| Quetiapine Fumarate Generic | 114 | 195 | 33 | $1,127 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 109 | 232 | 38 | $5,397 |
| Gocovri Amantadine Hcl | 106 | 126 | 13 | $392K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 96 | 247 | 29 | $2,503 |
| Nuplazid Pimavanserin Tartrate | 96 | 100 | 15 | $475K |
| Propranolol Hcl Er Propranolol Hcl | 85 | 192 | 26 | $5,721 |
| Baclofen Generic | 81 | 158 | 29 | $2,153 |
| Zonisamide Generic | 80 | 136 | 17 | $2,769 |
Brand drugs: 907 claims; generic drugs: 3,986 claims; opioid claims: 93.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aaron L Ellenbogen $473K ($276K in general payments such as food, travel and fees and $197K for research) from 22 companies. The largest payer was Amneal Pharmaceuticals LLC with $203K.
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC AMRX | 18 | $203K |
| Abbvie Inc. ABBV | 105 | $106K |
| MDD US Operations, LLC | 98 | $103K |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 26 | $38K |
| Teva Pharmaceuticals USA, Inc. TEVA | 17 | $17K |
| Tanabe Pharma America, Inc. | 2 | $4,225 |
| F. Hoffmann-La Roche AG ROG.SW | 2 | $1,280 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $213 |
| Revance Therapeutics, Inc. | 1 | $83.37 |
| Supernus Pharmaceuticals, Inc. SUPN | 1 | $79.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.